Łacina, P.; Butrym, A.; Turlej, E.; Stachowicz-Suhs, M.; Wietrzyk, J.; Mazur, G.; Bogunia-Kubik, K.
BSG (CD147) Serum Level and Genetic Variants Are Associated with Overall Survival in Acute Myeloid Leukaemia. J. Clin. Med. 2022, 11, 332.
https://doi.org/10.3390/jcm11020332
AMA Style
Łacina P, Butrym A, Turlej E, Stachowicz-Suhs M, Wietrzyk J, Mazur G, Bogunia-Kubik K.
BSG (CD147) Serum Level and Genetic Variants Are Associated with Overall Survival in Acute Myeloid Leukaemia. Journal of Clinical Medicine. 2022; 11(2):332.
https://doi.org/10.3390/jcm11020332
Chicago/Turabian Style
Łacina, Piotr, Aleksandra Butrym, Eliza Turlej, Martyna Stachowicz-Suhs, Joanna Wietrzyk, Grzegorz Mazur, and Katarzyna Bogunia-Kubik.
2022. "BSG (CD147) Serum Level and Genetic Variants Are Associated with Overall Survival in Acute Myeloid Leukaemia" Journal of Clinical Medicine 11, no. 2: 332.
https://doi.org/10.3390/jcm11020332
APA Style
Łacina, P., Butrym, A., Turlej, E., Stachowicz-Suhs, M., Wietrzyk, J., Mazur, G., & Bogunia-Kubik, K.
(2022). BSG (CD147) Serum Level and Genetic Variants Are Associated with Overall Survival in Acute Myeloid Leukaemia. Journal of Clinical Medicine, 11(2), 332.
https://doi.org/10.3390/jcm11020332